Did Cellebrite’s 2026 Guidance and Forensics Acquisitions Just Recast CLBT’s SaaS Investment Narrative?
Summary
Cellebrite reported Q4 revenue of $128.82M and FY2025 revenue of $475.68M and guided to $126–$128M for Q1 2026 and $565–$571M for FY2026. The company closed the Corellium acquisition and is acquiring SCG Canada to expand ARM device, drone, and broader digital-forensics capabilities. Management's 2026 guidance points to higher adjusted EBITDA margins, shifting the investment narrative toward profitability and product-driven margin expansion alongside recurring SaaS growth. How well Cellebrite integrates Corellium and converts the expanded toolkit into higher ARR and stickier government contracts will determine whether it achieves its longer-term revenue and earnings targets. Investors should weigh Simply Wall St's $24.71 fair value and bullish scenarios against concentrated exposure to U.S. government budgets and integration risks.
